TY  - JOUR
AU  - Udaondo, Clara
AU  - Cámara, Carmen
AU  - Miguel Berenguel, Laura
AU  - Alcobendas Rueda, Rosa
AU  - Muñoz Gómez, Celia
AU  - Millán Longo, Claudia
AU  - Díaz-Delgado, Blanca
AU  - Falces-Romero, Iker
AU  - Díaz Almirón, Mariana
AU  - Ochando, Jordi
AU  - Méndez-Echevarría, Ana
AU  - Remesal Camba, Agustín
AU  - Calvo, Cristina
PY  - 2022
DO  - 10.1186/s12969-022-00724-4
UR  - http://hdl.handle.net/20.500.12105/15289
AB  - Background: Data about safety and efficacy of the mRNA SARS-CoV-2 vaccine in adolescents with rheumatic diseases (RD) is scarce and whether these patients generate a sufficient immune response to the vaccine remains an outstanding question. Objective:...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Children
KW  - COVID-19
KW  - Juvenile Idiopathic Arthritis
KW  - Methotrexate
KW  - TNF inhibitors
KW  - mRNA vaccination
KW  - COVID-19
KW  - Rheumatic Diseases
KW  - Viral Vaccines
KW  - Adolescent
KW  - BNT162 Vaccine
KW  - COVID-19 Vaccines
KW  - Humans
KW  - Immunity, Cellular
KW  - Interleukin-2
KW  - Methotrexate
KW  - RNA, Messenger
KW  - SARS-CoV-2
KW  - Tumor Necrosis Factor Inhibitors
TI  - Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases
TY  - journal article
ER  -